全球血清市场 – 行业趋势及 2031 年预测

血清市场分析和规模

由于几个关键因素，市场正在经历显着增长。主要驱动因素之一是血清在各种应用中的使用越来越多，包括细胞培养、诊断和生物制药生产。对基于细胞的疗法和再生医学的不断增长的需求正在推动市场增长，因为血清对于支持细胞生长和活力至关重要。受细胞培养技术进步以及血清在研究和临床应用中日益普及的推动，市场预计将增长。

2023 年全球血清市场规模价值 15.7 亿美元，预计到 2031 年将达到 33.7 亿美元，2024 年至 2031 年预测期内的复合年增长率为 10%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

Market Definition

Serum refers to the clear, yellowish fluid that remains after blood has clotted and the clot has been removed. It is essentially blood plasma without the clotting factors. The serum contains water, electrolytes, antibodies, antigens, hormones, and any exogenous substances (e.g., drugs or microorganisms) in the blood.                      

Serum Market Dynamics

Drivers

• Growing Biopharmaceutical Industry 

The biopharmaceutical industry is witnessing significant growth due to the increasing prevalence of chronic diseases and the demand for personalized medicine. Biopharmaceuticals often require serum in their production processes, driving the demand for serum products. The development of novel therapies, including biologics and biosimilars, further boost the demand for serum. In addition, the rise in healthcare expenditure and investments in research and development are contributing to the expansion of the biopharmaceutical industry, driving market growth.      

• Rising Demand for Cell Culture Technology  

Cell culture technology is crucial in pharmaceutical and biotechnology research, allowing researchers to study cell behavior and develop new therapies. Serum is often employed as a growth supplement in cell culture media to support the growth and proliferation of cells. The increasing adoption of cell culture techniques in drug discovery, regenerative medicine, and vaccine production drives the demand for serum. Moreover, advancements in cell culture technology, such as the development of serum-free media and three-dimensional (3D) cell culture systems, are expanding cell culture applications, further fueling the demand for serum products.        

Opportunities

• Increasing Prevalence of Chronic Diseases

Chronic diseases are rising due to factors such as aging populations, unhealthy lifestyles, and environmental factors. Chronic diseases such as cancer, diabetes, and cardiovascular disorders utilize serum samples for regular monitoring through diagnostic tests. As the prevalence of these diseases continues to increase, the demand for diagnostic tests is also expected to rise, creating a significant market opportunity for serum-based diagnostics and opportunities for the serum market to grow.    

• Growing Research and Development Activities

The life sciences and biotechnology sectors are experiencing rapid growth, driven by technological advancements, increasing funding for research, and a growing focus on personalized medicine. This growth has led to expanding research and development activities in areas such as stem cell research, regenerative medicine, and drug discovery. Serum plays a vital role in numerous research applications, providing a nutrient-rich medium for cell culture and serving as a source of biomarkers for various studies. The growing demand for serum in research and development activities presents a significant market opportunity for serum manufacturers and suppliers. As research advances, the demand for high-quality serum products is expected to remain strong, creating opportunities for market growth.

Restraints/Challenges

• Ethical Concerns Regarding Animal Welfare

Serum is traditionally obtained from animal sources, primarily fetal bovine serum (FBS), which raises ethical concerns regarding animal welfare. The process of collecting serum from fetal bovine blood involves the slaughter of pregnant cows, leading to criticism from animal rights groups and some researchers. To address these concerns, there has been an increasing focus on the development of cell culture media that do not require serum. These alternative media formulations aim to eliminate the need for serum derived from animals, which could potentially limit the growth of the serum market in the future.

• High Cost of Serum

Serum, particularly FBS, is a relatively expensive component of cell culture media. The high cost of serum can be attributed to various factors, including the labor-intensive process of collecting and processing serum and the limited availability of FBS due to strict regulations on its production and export. The high serum cost can pose a barrier to its widespread use, especially in research settings with limited budgets. As a result, researchers and biotechnology companies are exploring alternative media formulations that can achieve similar results at a lower cost, potentially impacting the demand for serum in the market.

This serum market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serum market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Serum Market Scope

根据类型、灭活技术、应用、销售渠道和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 牛血清
• 胎牛血清
• 其他

 灭活技术

• 热灭活
• 非热灭活

 应用

• 生物制品
• 研究
• 细胞培养
• 生物制药药物
• 疫苗产品
• 诊断产品
• 其他的

最终用户

• 生物制药及生物技术行业
• 诊断实验室
• 研究实验室
• 学术研究

 销售渠道

• 直销渠道
• 分销渠道

血清市场区域分析/见解

对市场进行分析，并按国家、类型、灭活技术、应用、销售渠道和最终用户提供市场规模洞察和趋势，如上所述。

市场覆盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。

由于北美地区越来越重视生物产品研究，因此预计北美将主导市场。完善的医疗基础设施、先进医疗技术的广泛采用以及对研发的大量投资也推动了市场的增长。

由于技术进步不断加快、老年人口不断增加、慢性病患病率不断上升以及医疗基础设施不断改善等因素，预计亚太地区在预测期内将出现显著增长。此外，中国、印度和日本等国家生物制药和生命科学产业的扩张也有助于该地区的增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区医疗资本设备支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对血清市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和血清市场份额分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• 赛默飞世尔科技公司（美国）
• 默克集团（德国）
• Cytiva (美国)
• Bio-Techne (美国)
• Atlas Biologicals, Inc.（美国）
• Rocky Mountain Biologicals（美国）
• Takara Bio Inc.（日本）
• PAN-Biotech（德国）
• Sartorius AG（德国）
• 康宁公司（美国）
• Bovogen Biologicals Pty Ltd.（澳大利亚）
• Moregate Biotech（澳大利亚）
• BIOWEST SAS（法国）
• Caisson Labs Inc.（美国）
• Gemini Bio（美国）

SKU-56873